US Broker Ratings

Taysha Gene Therapies (TSHA) Investor Outlook: Exploring a Promising 147% Upside Potential

As Taysha Gene Therapies, Inc. (TSHA) navigates the complex landscape of biotechnology, investors are keenly eyeing its potential for significant growth. With a market capitalization of..

Upstream Bio, Inc. (UPB) Stock Analysis: Exploring a 433% Potential Upside in Biotech

For investors looking to capitalize on the biotech sector’s potential, Upstream Bio, Inc. (NASDAQ: UPB) stands out as a compelling opportunity. With a remarkable 433.48% potential..

Verastem, Inc. (VSTM): A Biotech Stock with Over 110% Potential Upside According to Analyst Ratings

Verastem, Inc. (NASDAQ: VSTM), a development-stage biopharmaceutical company, stands out in the biotechnology sector with its promising pipeline focused on cancer treatment. With a market capitalization..

Definitive Healthcare Corp. (DH) Stock Analysis: Is a 30.99% Upside Worth the Risk?

Definitive Healthcare Corp. (NASDAQ: DH) presents a compelling opportunity for investors intrigued by the intersection of healthcare and technology. Specializing in healthcare commercial intelligence, Definitive Healthcare..

Tilray Brands, Inc. (TLRY) Investor Outlook: Exploring a Potential 189.62% Upside

Tilray Brands, Inc. (NASDAQ: TLRY), a leading lifestyle consumer products company in the healthcare sector, has sparked significant interest among investors due to the potential upside..

Embecta Corp. (EMBC) Stock Analysis: Exploring a 73.73% Potential Upside in Healthcare Innovation

In the dynamic world of healthcare investments, Embecta Corp. (NASDAQ: EMBC) presents a compelling case for investors seeking opportunities in the medical instruments and supplies sector...

COMPASS Pathways Plc (CMPS) Investor Outlook: Exploring a Potential 313% Upside in the Mental Health Revolution

As the healthcare sector continues to evolve, COMPASS Pathways Plc (NASDAQ: CMPS) stands at the forefront of pioneering mental health solutions. With a focus on innovative..

HealthStream, Inc. (HSTM) Stock Analysis: Exploring a 24.01% Potential Upside for Investors

HealthStream, Inc. (NASDAQ: HSTM) is a notable player in the healthcare sector, specifically within the health information services industry. With a market capitalization of approximately $849.21..

AxoGen, Inc. (AXGN) Stock Analysis: Exploring a 123% Potential Upside in the Medical Devices Sector

AxoGen, Inc. (NASDAQ: AXGN), a pivotal player in the healthcare sector, is garnering attention with its impressive potential upside of 123%. Specializing in the medical devices..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Potential 65% Upside in Biotech’s Fight Against Hepatitis B

Arbutus Biopharma Corporation (NASDAQ: ABUS) stands at the forefront of innovative treatments in the biotechnology sector, focusing on developing novel therapeutics for infectious diseases, particularly chronic..

Enhabit, Inc. (EHAB) Stock Analysis: Navigating Challenges in Healthcare with a Modest Upside

Enhabit, Inc. (EHAB), a key player in the U.S. healthcare sector, specializes in providing comprehensive home health and hospice services. With a market capitalization of $519.54..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Unveiling a Potential 125% Upside with Strong Buy Ratings

Castle Biosciences, Inc. (NASDAQ: CSTL), a pioneering force in the molecular diagnostics space, stands out for its promising potential in the healthcare sector. As of the..

RxSight, Inc. (RXST) Stock Analysis: Unveiling a 33% Potential Upside Amidst Medical Device Innovation

RxSight, Inc. (NASDAQ: RXST) emerges as a compelling player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of approximately $645.72..

Zymeworks Inc. (ZYME) Stock Analysis: Exploring an 87.77% Potential Upside in the Biotechnology Sector

Zymeworks Inc. (NASDAQ: ZYME), a clinical-stage biotechnology company, stands out in the healthcare sector with its innovative approach to biotherapeutics, particularly in oncology and autoimmune diseases...

SI-BONE, Inc. (SIBN) Stock Analysis: Navigating a 33.91% Upside Potential in the Medical Device Space

For investors eyeing opportunities in the healthcare sector, SI-BONE, Inc. (NASDAQ: SIBN) presents a compelling case, particularly with a potential upside of 33.91% based on its..

Cogent Biosciences, Inc. (COGT): A Lucrative Investment with 226.91% Upside Potential

Cogent Biosciences, Inc. (NASDAQ: COGT) is a biotechnology company that has caught the attention of investors, particularly with its impressive potential upside of 226.91%. Specializing in..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Exploring a Potential 91% Upside in the Biotech Sector

ArriVent BioPharma, Inc. (NASDAQ: AVBP) has garnered significant attention in the biotechnology sector, primarily due to its ambitious focus on cancer therapies and a remarkable potential..

Auna SA (AUNA) Stock Analysis: Potential Upside of 85.48% Sparks Investor Interest

Auna SA (AUNA), a prominent player in the healthcare sector, is capturing the attention of investors with its significant growth potential. Despite a challenging economic environment,..

Talkspace, Inc. (TALK) Stock Analysis: Exploring a Promising 81% Upside Potential

Talkspace, Inc. (NASDAQ: TALK) is carving out a significant niche in the healthcare sector, specifically within health information services, by offering virtual behavioral healthcare. Headquartered in..

Vir Biotechnology, Inc. (VIR): Investor Outlook with a Potential Upside of 287.74%

Vir Biotechnology, Inc. (NASDAQ: VIR) presents a unique opportunity within the biotechnology sector, particularly for investors who are keen on high-risk, high-reward profiles. With a current..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds